Induction of Cell Death in Neuroblastoma by Inhibition of Cathepsins B and L
Overview
Authors
Affiliations
A specific irreversible inhibitor of both cathepsins B and L, Fmoc-Tyr-Ala-CHN(2) (FYAD) induced apoptosis of neuroblastoma cells but not other tumor cells. Cysteine protease inhibitors that were not efficient inhibitors of both proteases did not cause death of any cell line tested. Apoptosis was preceded by accumulation of large electron dense vesicles and multivesicular bodies in the cytoplasm. Exposure of cells to the cathepsin D inhibitor, pepstatin, failed to rescue cells from FYAD-induced death. These results indicate that inhibition of cathepsins B and L may provide a unique mechanism for selectively inducing death of neuroblastoma with limited toxicity to normal cells and tissues.
Targeting lysosomes in human disease: from basic research to clinical applications.
Cao M, Luo X, Wu K, He X Signal Transduct Target Ther. 2021; 6(1):379.
PMID: 34744168 PMC: 8572923. DOI: 10.1038/s41392-021-00778-y.
The Role of Cysteine Cathepsins in Cancer Progression and Drug Resistance.
Rudzinska M, Parodi A, Soond S, Vinarov A, Korolev D, Morozov A Int J Mol Sci. 2019; 20(14).
PMID: 31340550 PMC: 6678516. DOI: 10.3390/ijms20143602.
Soori M, Lu G, Mason R J Pharmacol Exp Ther. 2015; 356(2):375-86.
PMID: 26660229 PMC: 4746490. DOI: 10.1124/jpet.115.229229.
Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response.
Olson O, Joyce J Nat Rev Cancer. 2015; 15(12):712-29.
PMID: 26597527 DOI: 10.1038/nrc4027.
Loser R, Pietzsch J Front Chem. 2015; 3:37.
PMID: 26157794 PMC: 4477214. DOI: 10.3389/fchem.2015.00037.